Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

The Importance of Selecting The Most Promising Drug Target

Posted on September 27th, 2017 by in Pharma R&D

The growing economic pressure due to late-stage drug approval failures has been forcing drug discovery and development scientists to adapt their strategies in order to increase their chances of success. Continue reading “The Importance of Selecting The Most Promising Drug Target” »

Assessing DDI Risk in the Digital Age

Posted on August 9th, 2017 by in Pharmacovigilance

pills pic for SD case study
In their 2012 Drug Regulations, the U.S. Food and Drug Administration recommended that “pharmacokinetic interactions between an investigational new drug and other drugs should be defined during drug development.”

Continue reading “Assessing DDI Risk in the Digital Age” »

The Power of Two in Lead Optimization

Posted on July 3rd, 2017 by in Chemistry

The rise of in silico approaches has revolutionized early drug discovery, making it possible to model the potential in vivo behaviors of large numbers of compounds, delve deep into their bioactive and chemical properties, Continue reading “The Power of Two in Lead Optimization” »

Arctic Pharma: Our Latest Steps Towards Innovation

Posted on December 15th, 2016 by in Pharma R&D

At a high level, we at Arctic Pharma are working on innovative therapies for cancer that have minimal side effects. More specifically, we are targeting certain enzymes that are up-regulated in cancer cell metabolism using inhibitors that we have designed. Continue reading “Arctic Pharma: Our Latest Steps Towards Innovation” »